Dvorakova, Marcela; Langhansova, Lenka; Temml, Veronika; Pavicic, Antonio; Vanek, Tomas; Landa, Premysl published the artcile< Synthesis, Inhibitory Activity and In Silico Modeling of Selective COX-1 Inhibitors with a Quinazoline Core>, Application In Synthesis of 20776-50-5, the main research area is quinazoline preparation cyclooxygenase inhibitor docking.
Three series of quinazoline derivatives I [R1 = 4-H2NC6H4O, 4-MeOC6H4CH2NH, 4-MeC6H4NH, etc.; R2 = CH:CHPh, Et2N, morpholino, pyrrolidin-1-yl, piperazin-1-yl; R3 = H, 4-MeOC6H4, 4-FC6H4, 2-thienyl] were prepared and tested for their potential inhibitory activity toward COX-1 and COX-2. Of the prepared compounds, 11 exhibited interesting COX-1 selectivity, with 8 compounds being totally COX-1-selective. The IC50 value of the best quinazoline inhibitor was 64 nM. The structural features ensuring COX-1 selectivity were elucidated using in silico modeling.
ACS Medicinal Chemistry Letters published new progress about Amines Role: RCT (Reactant), RACT (Reactant or Reagent). 20776-50-5 belongs to class bromides-buliding-blocks, and the molecular formula is C7H6BrNO2, Application In Synthesis of 20776-50-5.
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary